ArticleBMC gastroenterology2026
Identification of IL1RN, MUC1, and SERPINA1 as key NET-related biomarkers in ulcerative colitis-associated intestinal fibrosis via bioinformatics and experimental validation.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLong-term recurrent episodes of ulcerative colitis (UC) can lead to intestinal fibrosis (IF), which severely affects patient prognosis. Neutrophil extracellular traps (NETs) have been identified as critical drivers of various fibrotic diseases; however, their precise role and regulatory mechanisms in UC-associated intestinal fibrosis (UC-IF) remain to be systematically elucidated. Therefore, identifying the key regulatory genes through which NETs participate in UC-IF is highly important for the diagnosis and treatment of this condition.
methodsIn this study, we analyzed the gene expression profiles of UC patients via publicly available databases and screened for neutrophil extracellular trap-related differentially expressed genes (NET-DEGs), identifying a total of 99 NET-DEGs. Enrichment analysis was then performed to explore the biological processes involving these genes. Furthermore, this study identified 5 potentially key NET-DEGs using machine learning algorithms. On the basis of these 5 genes, combined with protein-protein interaction (PPI) network analysis, intestinal fibrosis-related gene set variation analysis (GSVA), and immune infiltration analysis, we identified NET-related biomarkers associated with UC-IF. Finally, we established a mouse model of UC-IF in vivo to validate the bioinformatics findings.
resultsThis analysis revealed that IL1RN, MUC1, and SERPINA1 represent a novel panel of NET-related biomarkers for UC-IF. These genes were enriched in immune responses, interleukin signaling pathways, O-glycan biosynthesis, and mucosal barrier-related pathways. Furthermore, these genes were positively correlated with several immune cell types, including neutrophils, macrophages (M0 and M1), and dendritic cells, collectively mediating immune dysregulation in UC and thereby contributing to the pathogenesis of UC-IF. Notably, animal experiments further validated the aberrantly high expression of these genes in the intestinal tissues of UC-IF mice, which was consistent with the bioinformatics findings.
conclusionsAs UC-IF-associated NET biomarkers, IL1RN, MUC1 and SERPINA1 provide novel insights into the clinical diagnosis, treatment, and translational research of UC-IF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.